Evaluation of the palatabilities in 10 different famotidine orally disintegrating tablets by combination of disintegration device and taste sensor

References

• Bi Y, Sunada H, Yonezawa Y, et al. Preparation and evaluation of a compress tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996;44:2121–7
   PubMed Web of Science ®Google Scholar
• Masuda Y. The current and formulation design of fast oral-disintegrating tablets. Pharm Tech Jpn 2006;22:401–12
   Google Scholar
• Narazaki R, Harada T, Takami N, et al. A new method for disintegration studies of rapid disintegrating tablet. Chem Pharm Bull 2004;52:704–7
   PubMed Web of Science ®Google Scholar
• Kashima A, Kobayashi T, Kobayashi M, et al. Evaluation of quality of orodispersible famotidine tablets. Jpn J Health Care Sci 2006;32:511–16
   Google Scholar
• Hashimoto Y, Matsunaga C, Tokuyama E, et al. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor. Chem Pharm Bull 2007;55:739–46
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia 8.0. Orodispersible tablets. France: European Directorade for the quality of medicine and healthcare, 2014:811
   Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: orally disintegrating tablets. Silver Spring, MD: U.S. Department of Health and Human Services; 2008
   Google Scholar
• Harada T, Narazaki R, Nagira S, et al. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull 2006;54:1072–5
   PubMed Web of Science ®Google Scholar
• Kakutani R, Muro H, Makino T. Development of a new disintegration method for orally disintegrating tablets. Chem Pharm Bull 2010;58:885–90
   PubMed Web of Science ®Google Scholar
• Tachiki H, Uchiyama H, Okuda Y, et al. Bitterness evaluation of famotidine orally disintegrating tablets using a taste sensor. Jpn J Med Pharm Sci 2005;54:321–7
   Google Scholar
• Hashimoto Y, Matsunaga C, Tokuyama E, et al. The quantitative prediction of bitterness-suppressing effect of sweeteners on the bitterness of famotidine by sweetness-responsive sensor. J Pharm Pharmacol 2002;54:1323–8
   PubMed Web of Science ®Google Scholar
• Akiyoshi T, Tanaka N, Nakamura T, et al. Effects of quinine on the intracellular calcium level and membrane potential of PC12. J Pharm Pharmacol 2007;59:1521–6
   PubMed Web of Science ®Google Scholar
• Yoshida M, Tokuyama E, Hazekawa M, Uchida T. Bitterness suppression of the Kampo medicine ‘orengedokuto’ using flavoured jellies. Chem Pharm Bull 2010;58:449–53
   PubMed Web of Science ®Google Scholar
• Ito M, Yoshida M, Kobayashi Y, et al. Bitterness evaluation of H1-receptor antagonists using a taste sensor. Sens Mater 2011;23:483–92
   Web of Science ®Google Scholar
• Katsuragi Y, Mitsui Y, Umeda T, et al. Basic studies for the practical use of bitterness inhibitors: selective inhibition of bitterness by phospholipids. Pharm Res 1997;14:720–4
   PubMed Web of Science ®Google Scholar
• Mizumoto T. Formulation design of a novel fast-disintegrating tablet. Int J Pharm 2005;306:83–90
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Matsubara K, Koida Y, Kobayashi M. The preparation of rapidly disintegrating tablets in the mouth. Pharm Dev Technol 2001;6:487–93
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Maejima T, Narisawa S, et al. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose. Int J Pharm 2005;296:64–72
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Narisawa S, Matsubara K, et al. Effect of formulated ingredients on rapidly disintegrating oral tablets prepared by crystalline transition method. Chem Pharm Bull 2006;54:175–80
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Narisawa S, Matsubara K, et al. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose. Int J Pharm 2006;320:71–8
   PubMed Web of Science ®Google Scholar
• Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release 2009;139:94–107
   PubMed Web of Science ®Google Scholar
• Abdelbary A, Elshafeey AH, Zidan G. Comparative effects of different cellulosic-based directly compressed orodispersable tablets on oral bioavailability of famotidine. Carbohydrate Polymers 2009;77:799–806
   Web of Science ®Google Scholar
• Nakano Y, Maeda A, Uchida S, Namiki N. Preparation and evaluation of unpleasant taste-masked pioglytazone orally disintegrating tablets. Int J Pharm 2013;446:160–5
   PubMed Web of Science ®Google Scholar
• Lou H, Liu M, Qu W, et al. Evaluation of chlorpheniramine maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics. Drug Dev Ind Pharm 2014;40:910–18
   PubMed Web of Science ®Google Scholar
• Dehaene S. The neural basis of the Weber-Fecher law: a logarithmic mental number line. Trend Cogn Sci 2003;7:145–7
   PubMed Web of Science ®Google Scholar
• Miyanaga Y, Inoue N, Ohnishi A, et al. Quantitative prediction of the bitterness suppression of elemental diets by various flavors using a taste sensor. Pharm Res 2003;20:1932–8
   PubMed Web of Science ®Google Scholar
• Uchida T, Sugino Y, Hazekawa M, et al. Factors affecting the bitterness intensities of ten commercial formulations of ambroxol. Chem Pharm Bull 2012;60:949–54
   PubMed Web of Science ®Google Scholar
• Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 2004;30: 429–48
   PubMed Web of Science ®Google Scholar
• Choi du H, Kim NA, Nam TS, et al. Evaluation of taste-masking effects of pharmaceutical sweeteners with an electronic tongue system. Drug Dev Ind Pharm 2014;40:308–17
   PubMed Web of Science ®Google Scholar